PMH29 ATTENTION DEFICIT HYPERACTIVITY DISORDER MEDICATION CLINICAL PRIOR AUTHORIZATION PROGRAM'S IMPACT ON PRESCRIPTION DRUG UTILIZATION AND COSTS
2014 ◽
Vol 116
(4)
◽
pp. 349-353
◽
2014 ◽
Vol 28
(6)
◽
pp. 530-536
◽
2006 ◽
Vol 48
(06)
◽
pp. 483
◽
Assessment of Attention-Deficit/Hyperactivity Disorder: An Evaluation of Six Published Rating Scales
2003 ◽
Vol 32
(2)
◽
pp. 241-262
◽
2015 ◽
Vol 29
(1)
◽
pp. 26-32
◽
2000 ◽
Vol 68
(3)
◽
pp. 489-499
◽